scPharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference

Rhea-AI Summary

scPharmaceuticals (Nasdaq: SCPH), a pharmaceutical company dedicated to enhancing patient care and reducing healthcare costs, announced that CEO John Tucker will present at the Jefferies Virtual London Healthcare Conference on November 18, 2020, at 12:35 EDT / 5:35 GMT. The presentation will provide insights into the company's ongoing efforts to develop innovative therapies that facilitate outpatient care for acute conditions. A live webcast will be available on the company's website under the Investor Relations section.

BURLINGTON, Mass., Nov. 11, 2020 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize therapies, advance patient care, and reduce healthcare costs, today announced that John Tucker, president & chief executive officer, is scheduled to present at the Jefferies Virtual London Healthcare Conference on Wednesday, November 18 at 12:35 EDT / 5:35 GMT.

A live webcast of the presentation can be accessed under “News & Events” in the Investor Relations section of the Company’s website, www.scpharmaceuticals.com.

About scPharmaceuticals
scPharmaceuticals is a pharmaceutical company focused on developing and commercializing products that are designed to reduce healthcare costs and improve health outcomes. The Company develops, internally and through strategic partnerships, innovative products and solutions that aim to expand and advance the outpatient care of select acute conditions. The Company’s lead programs focus on the subcutaneous, self-administration of IV-strength treatments in heart failure and infectious disease. scPharmaceuticals is headquartered in Burlington, MA. For more information, please visit www.scPharmaceuticals.com.

Katherine Taudvin
scPharmaceuticals Inc., 781-301-6706
ktaudvin@scpharma.com

Investors:
Hans Vitzthum
LifeSci Advisors, 617-430-7578
hans@lifesciadvisors.com

Media:
Kate Coyle
ICR Inc., 203-682-8210
kate.coyle@icrinc.com

FAQ

What event is scPharmaceuticals participating in on November 18, 2020?

scPharmaceuticals will present at the Jefferies Virtual London Healthcare Conference.

Who will represent scPharmaceuticals at the Jefferies Conference?

CEO John Tucker will represent scPharmaceuticals at the conference.

Where can I watch the scPharmaceuticals presentation live?

The presentation can be accessed via a live webcast on the Investor Relations section of scPharmaceuticals' website.

What is the primary focus of scPharmaceuticals?

scPharmaceuticals focuses on developing products to optimize therapies, advance patient care, and reduce healthcare costs.

What is the stock symbol for scPharmaceuticals?

The stock symbol for scPharmaceuticals is SCPH.